Hypnotics and driving: FDA action, clinical trials show need for precautions
Drugs’ effects on performance and memory differ, depending on time since administration.
When you make patients aware of all risks, benefits, alternate therapies, and possible outcomes with no treatment, you have informed them effectively. Patients are then left to decide whether or not to agree to the treatment. You also are responsible for monitoring the patient, addressing the patient’s questions, and relaying important safety information.
When prescribing zolpidem, discuss safety information with the patient, such as:
- Do not drive or operate heavy equipment for at least 5 to 6 hours after administration.
- Have a safety plan in place for transportation during those hours.
- Do not use this medication with alcohol or other sedative/hypnotics.
- Contact the prescriber about any suspected adverse effects.
- MedlinePlus information on sleep disorders. National Institutes of Health and National Library of Medicine. www.nlm.nih.gov/medlineplus/sleepdisorders.html.
- Zolpidem (systemic). Mayoclinic.com: Tools for healthier lives. www.mayoclinic.com/health/drug-information/DR202707.
- Diazepam • Valium
- Eszopiclone • Lunesta
- Midazolam • Versed
- Oxazepam • Serax
- Quazepam • Doral
- Rofecoxib • Vioxx
- Temazepam • Restoril
- Triazolam • Halcion
- Zolpidem • Ambien, Ambien CR
- Zaleplon • Sonata
- Zopiclone • Imovane (in Europe)
The authors report no financial relationships with any company whose products are mentioned in this article or with manufacturers of competing products.
Acknowledgments
The authors acknowledge the assistance and guidance of Linda T. Moore, JD, in preparing this manuscript.
